{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:10:27Z","timestamp":1778616627761,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.oooo.2020.10.015","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T09:52:07Z","timestamp":1603014727000},"page":"49-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The blue palate\u2014A case series of imatinib-related oral pigmentation and literature review"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-5025","authenticated-orcid":false,"given":"Christopher C.","family":"Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-7483","authenticated-orcid":false,"given":"Richard L.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2496-1805","authenticated-orcid":false,"given":"Marco","family":"Carrozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2020.10.015_bib0001","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tripleo.2007.07.047","article-title":"Pigmented lesions of the oral mucosa and perioral tissues: a flow chart for the diagnosis and some recommendations for management","volume":"105","author":"Meleti","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.10.015_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40902-017-0136-y","article-title":"Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib","volume":"39","author":"Bombeccari","year":"2017","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"10.1016\/j.oooo.2020.10.015_bib0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tripleo.2010.11.006","article-title":"Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases","volume":"111","author":"Mattsson","year":"2011","journal-title":"Oral Surg Oral Med Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.10.015_bib0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jds.2019.02.005","article-title":"Imatinib-related hyperpigmentation of oral mucosa: case report and literature review","volume":"14","author":"Mascitti","year":"2019","journal-title":"J Dent Sci"},{"key":"10.1016\/j.oooo.2020.10.015_bib0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcms.2011.07.010","article-title":"Imatinib-associated hyperpigmentation of the palate in post-HSCT patient","volume":"40","author":"Resende","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.015_bib0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00128071-200102040-00006","article-title":"Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment","volume":"2","author":"Dereure","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0007","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5005\/jcdp-4-3-76","article-title":"The normal and pathological pigmentation of oral mucous membrane: a review","volume":"4","author":"Ci\u04abek","year":"2003","journal-title":"J Contemp Dent Pract"},{"key":"10.1016\/j.oooo.2020.10.015_bib0008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ors.12194","article-title":"Intraoral hyperpigmentation due to imatinib mesylate. A review of the literature","volume":"9","author":"Pancholi","year":"2016","journal-title":"Oral Surg"},{"key":"10.1016\/j.oooo.2020.10.015_bib0009","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0010","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1007\/s00784-019-02886-0","article-title":"Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review","volume":"23","author":"Oliveira","year":"2019","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.oooo.2020.10.015_bib0011","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12105-011-0325-4","article-title":"Mucosal pigmentation caused by imatinib: report of three cases","volume":"6","author":"Li","year":"2012","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0012","first-page":"1","article-title":"Mucosal pigmentation of the hard palate in a patient taking imatinib","volume":"16","author":"Lyne","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.oooo.2020.10.015_bib0013","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.leu.2403006","article-title":"Randomized comparison of interferon \u03b1 and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon \u03b1 and hydroxyurea","volume":"17","author":"Hehlmann","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.oooo.2020.10.015_bib0014","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.7314\/APJCP.2015.16.17.7555","article-title":"Treatment and survival in patients with chronic myeloid leukemia in a chronic phase in West Iran","volume":"16","author":"Payandeh","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.oooo.2020.10.015_bib0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/ijd.13931","article-title":"Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature","volume":"57","author":"Di Tullio","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0016","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5021\/ad.2014.26.4.532","article-title":"Imatinib mesylate\u2013induced hyperpigmentation of the nose and palate","volume":"26","author":"Song","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0017","unstructured":"British National Formulary. Imatinib. https:\/\/bnf.nice.org.uk\/drug\/imatinib.html#sideEffects. Accessed March 25, 2020."},{"key":"10.1016\/j.oooo.2020.10.015_bib0018","unstructured":"Hale C. Ephelis. https:\/\/www.pathologyoutlines.com\/topic\/skintumormelanocyticephelis.html. Accessed March 11, 2020."},{"key":"10.1016\/j.oooo.2020.10.015_bib0019","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.coc.0000170805.14058.d3","article-title":"Head and neck mucosal melanoma","volume":"28","author":"Mendenhall","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1067\/mjd.2003.44","article-title":"Adverse cutaneous reaction to imatinib (STI571) in Philadelphia chromosome\u2013positive leukemias: a prospective study of 54 patients","volume":"48","author":"Valeyrie","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0021","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdh068","article-title":"Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate","volume":"15","author":"Arora","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0378-6323.19727","article-title":"Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia","volume":"72","author":"Prabhash","year":"2006","journal-title":"Indian J Dermatol Venerol Leprol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0023","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPH.0b013e318033a76c","article-title":"Imatinib-induced dental hyperpigmentation in childhood chronic myeloid leukemia","volume":"29","author":"Singh","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0024","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaad.2008.06.029","article-title":"Imatinib mesylate\u2013induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumour","volume":"59","author":"Han","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0025","first-page":"7","article-title":"Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST","volume":"14","author":"Alexandrescu","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.oooo.2020.10.015_bib0026","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-3083.2008.02706.x","article-title":"Imatinib-associated hyperpigmentation, a side effect that should be recognized","volume":"23","author":"McPherson","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0027","first-page":"24","article-title":"Diffuse pigmentation of the palate","volume":"100","author":"Lewis","year":"2009","journal-title":"J Okla Dent Assoc"},{"key":"10.1016\/j.oooo.2020.10.015_bib0028","first-page":"4","article-title":"Oral melanosis after tyrosine kinase inhibition with imatinib for chronic myelogenous leukemia: report of a case and review of the literature","volume":"17","author":"Wong","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.oooo.2020.10.015_bib0029","first-page":"1062","article-title":"Pigmentary changes in a patient treated with imatinib","volume":"10","author":"Balagula","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2230.2011.04196.x","article-title":"Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib","volume":"37","author":"Steele","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0031","first-page":"764","article-title":"Oral and maxillofacial pathology case of the month. Palatal melanosis associated with imatinib mesylate therapy","volume":"129","author":"Yu","year":"2012","journal-title":"Tex Dent J"},{"key":"10.1016\/j.oooo.2020.10.015_bib0032","first-page":"79","article-title":"Rare oral manifestation of chronic myelogenous leukemia and its targeted therapy: a case report and literature review","volume":"1","author":"Loudon","year":"2012","journal-title":"Univ J Med Dent"},{"key":"10.1016\/j.oooo.2020.10.015_bib0033","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4321\/S0213-12852013000600005","article-title":"Unusual pigmentation of the palate associated to imatinib","volume":"29","author":"L\u00f3pez-Labady","year":"2013","journal-title":"Av Odontoestomatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0034","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/10428194.2012.702904","article-title":"Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT","volume":"54","author":"Khoo","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oooo.2020.10.015_bib0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.23589","article-title":"Imatinib-associated melanosis of the palate","volume":"89","author":"Roeker","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0036","first-page":"30","article-title":"Palatal Hyperpigmentation in a patient with chronic myeloid leukaemia on imatinib mesylate therapy: a case report","volume":"3","author":"Hindocha","year":"2014","journal-title":"Face Mouth Jaw Surg"},{"key":"10.1016\/j.oooo.2020.10.015_bib0037","first-page":"161","article-title":"Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate","volume":"53","author":"Kagimoto","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0038","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/0019-5154.164447","article-title":"Imatinib-induced extensive hyperpigmentation in a case of chronic myeloid leukemia","volume":"60","author":"Balasubramanian","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0039","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4103\/0253-7613.169576","article-title":"Imatinib-induced dental hyperpigmentation in chronic myeloid leukemia in an adult female","volume":"47","author":"Agrawal","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0040","first-page":"1","article-title":"A rare case of melanosis of the hard palate mucosa in a patient with chronic myeloid leukemia","volume":"2015","author":"Romeo","year":"2015","journal-title":"Case Rep Dent"},{"key":"10.1016\/j.oooo.2020.10.015_bib0041","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/0378-6323.182387","article-title":"Imatinib induced melasma-like pigmentation: report of five cases and review of literature","volume":"82","author":"Ghunawat","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0042","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1902\/cap.2016.160050","article-title":"Oral effects and early implant survival results after imatinib discontinuation therapy for chronic myelogenous leukemia: a case report","volume":"7","author":"Dixon","year":"2017","journal-title":"Clin Adv Periodontics"},{"key":"10.1016\/j.oooo.2020.10.015_bib0043","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijom.2017.02.514","article-title":"Palatal hyperpigmentation associated with imatinib mesylate therapy: a report of 2 rare cases","volume":"46","author":"Shi","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.015_bib0044","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.oooo.2017.10.006","article-title":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases","volume":"125","author":"Tosios","year":"2018","journal-title":"Oral Surg Oral Med Oral Path Oral Rad"},{"key":"10.1016\/j.oooo.2020.10.015_bib0045","first-page":"95","article-title":"A large gray-blue macule on the hard palate as an adverse effect of imatinib","volume":"116","author":"Lueken","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.oooo.2020.10.015_bib0046","first-page":"139","article-title":"Pigmented lesions of the oral mucosa. Part 1","volume":"13","author":"Fern\u00e1ndez-Blanco","year":"2015","journal-title":"Derma Cosm\u00e9tica y Quir\u00fargica"},{"key":"10.1016\/j.oooo.2020.10.015_bib0047","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate\u2014a new oral targeted therapy","volume":"346","author":"Savage","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.oooo.2020.10.015_bib0048","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","article-title":"Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Goldman","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.oooo.2020.10.015_bib0049","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1002\/cncr.25273","article-title":"Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET)","volume":"116","author":"Cortes","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2020.10.015_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.0307-6938.2001.00947.x","article-title":"Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients","volume":"27","author":"Kumar","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0051","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/10428194.2010.546913","article-title":"Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors","volume":"52","author":"Calabretta","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oooo.2020.10.015_bib0052","doi-asserted-by":"crossref","first-page":"E266","DOI":"10.1111\/j.1365-2230.2008.03185.x","article-title":"Drug-induced pigmentation of hard palate and skin due to chronic chloroquine therapy: report of two cases","volume":"34","author":"Gallo","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0053","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(01)06903-3","article-title":"Imatinib for chronic myeloid leukemia: a nice mess","volume":"358","author":"Lim","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.oooo.2020.10.015_bib0054","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(01)06535-7","article-title":"Safety and efficacy of imatinib (STI 571) in metastatic gastrointestinal stromal tumours: a phase I study","volume":"358","author":"van Oosterom","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.oooo.2020.10.015_bib0055","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2147\/DDDT.S89114","article-title":"Receptor tyrosine kinase (c-KIT) inhibitors: a potential therapeutic target in cancer cells","volume":"10","author":"Babaei","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.oooo.2020.10.015_bib0056","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oooo.2020.10.015_bib0057","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/1078-0432.CCR-03-0110","article-title":"Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia","volume":"10","author":"Robson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oooo.2020.10.015_bib0058","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.292.22.2771","article-title":"Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria","volume":"292","author":"Abbasi","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.oooo.2020.10.015_bib0059","unstructured":"Bataille V, Anthony S.Toolbox\u2014the ABCDE criteria for pigmented skin lesions. http:\/\/www.pulsetoday.co.uk\/clinical\/clinical-specialties\/cancer\/toolbox-the-abcde-criteria-for-pigmented-skin-lesions\/20004750.article. Accessed March 11, 2020."},{"key":"10.1016\/j.oooo.2020.10.015_bib0060","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.18.01223","article-title":"Markedly reduced risk of internal malignancies in patients with vitiligo: a nationwide population-based cohort study","volume":"37","author":"Bae","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440320312827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440320312827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:07:10Z","timestamp":1761948430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440320312827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2212440320312827"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2020.10.015","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The blue palate\u2014A case series of imatinib-related oral pigmentation and literature review","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2020.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}